Wooridul Pharmaceutical Rises 5.22% Amid COVID-19 (Diagnostic Kit) Theme Uptrend

On the 27th, the COVID-19 (diagnostic kit) theme rose by 3.14% compared to the previous day, showing strength, while Wooridul Pharmaceutical, a related stock drawing attention, surged by 5.22% compared to the previous day. Wooridul Pharmaceutical is known as a pharmaceutical manufacturer and seller focused on therapeutics.

[Graph] Major stock price changes in the COVID-19 (diagnostic kit) theme

According to preliminary data compiled at 10:51, foreigners have purchased 56,100 shares of Wooridul Pharmaceutical, indicating a large net buying by foreign investors.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Wooridul Pharmaceutical’s quant financial score is 32.39 points, with higher growth and stability scores than the average of other stocks related to the COVID-19 (diagnostic kit) theme, ranking 14th within the theme. This indicates that compared to other stocks in the theme, Wooridul Pharmaceutical’s sales and net profit growth rates are relatively fast, and its ability to respond to changes in domestic and international economic environments is also favorable.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.